RE: Divmax29 Jul 2020 18:19
Hi M.D. I agree with you. What people are not noticing is that GSK are really starting to ramp up the vaccine side of the business. The healthcare side obviously will do well with what Pfizer have brought to the table.
The vaccine side is solid as they already as you say have a good pipline and proven vaccines that are doing well , so any failings ( not that they have any) in R&D are well covered.
This company is all about the next five years onwards. Not about making a few quid now.
Am holding onto Synairgen although I top sliced a bit, if it goes up on a favourable rns in the future and the herd arrives . the money is going here.